financetom
Business
financetom
/
Business
/
Cannae Holdings Q1 Loss Widens, Revenue Declines
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cannae Holdings Q1 Loss Widens, Revenue Declines
May 10, 2024 1:35 AM

04:15 AM EDT, 05/10/2024 (MT Newswires) -- Cannae Holdings ( CNNE ) reported a Q1 net loss late Thursday of $1.27 per diluted share, compared with a loss of $0.05 a year earlier.

Three analysts surveyed by Capital IQ expected a loss of $0.18.

Revenue for the quarter ended March 31 was $110.7 million, down from $154.3 million a year earlier.

Three analysts polled by Capital IQ expected $126.2 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kingsoft Cloud's Q2 Loss Widens, Revenue Rises
Kingsoft Cloud's Q2 Loss Widens, Revenue Rises
Aug 20, 2025
07:54 AM EDT, 08/20/2025 (MT Newswires) -- Kingsoft Cloud ( KC ) reported Wednesday a Q2 net loss of 0.11 Chinese renminbi ($0.01) per diluted share, compared with a loss of $0.10 renminbi a year earlier. Three analysts polled by FactSet expected a loss of 1.23 renminbi. Revenue for the quarter ended June 30 was 2.35 billion renminbi, up from...
Exclusive-China considering yuan-backed stablecoins to boost global currency usage, sources say
Exclusive-China considering yuan-backed stablecoins to boost global currency usage, sources say
Aug 20, 2025
(Reuters) -China is considering allowing the usage of yuan-backed stablecoins for the first time to boost wider adoption of its currency globally, sources familiar with the matter said, in a major reversal of its stance towards digital assets. The State Council - China's cabinet - will review and possibly approve a roadmap later this month for the greater usage of...
Jazz Pharmaceuticals Receives Global Rights to Saniona's Epilepsy Drug in More Than $1 Billion Deal
Jazz Pharmaceuticals Receives Global Rights to Saniona's Epilepsy Drug in More Than $1 Billion Deal
Aug 20, 2025
07:53 AM EDT, 08/20/2025 (MT Newswires) -- Jazz Pharmaceuticals ( JAZZ ) has obtained exclusive worldwide rights to develop and commercialize Saniona's experimental epilepsy drug, SAN2355, the companies said Wednesday. Saniona will receive an upfront payment of $42.5 million, with potential additional payments totaling over $1 billion, including development, regulatory, and commercial milestone payments, as well as royalties on future...
Enanta Pharmaceuticals Sues Pfizer Over COVID-19 Drug Patent in EU
Enanta Pharmaceuticals Sues Pfizer Over COVID-19 Drug Patent in EU
Aug 20, 2025
07:56 AM EDT, 08/20/2025 (MT Newswires) -- Enanta Pharmaceuticals ( ENTA ) said Wednesday that it has filed a lawsuit in the Unified Patent Court of the European Union against Pfizer ( PFE ) and certain of its units over alleged patent infringement. Enanta said it asked the court to determine liability for infringement of its European patent covering coronavirus...
Copyright 2023-2026 - www.financetom.com All Rights Reserved